Thursday, April 12, 2007

ESCR Funding Politics: It is About the Pork


Stock prices for embryonic stem cell research companies took a hit when the U.S. Senate failed to pass a bill to overturn President Bush's stem cell funding policy by a veto proof margin. Worcester, MA's, Advanced Cell Technology--which opened an office in California to try and take advantage of the cornicopia of Proposition 71 money--lost value, as did California's Geron. Some adult stem cell companies also lost ground, but others gained.

Well, the market doesn't lie: A big part of the drive to overturn Bush's policy is pure corporate welfare pork. Sooweeee!

Labels:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home